← Back to Search

Sugammadex for Burns

Phase 3
Waitlist Available
Led By Anthony Kovac, MD
Research Sponsored by University of Kansas Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Undergoing burn surgery under general anesthesia
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 24 hours after surgery
Awards & highlights

Study Summary

This trial will test if sugammadex is better than neostigmine for reversing neuromuscular blockade in burn patients.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 24 hours after surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 24 hours after surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Time to return to a 90% Train of Four (TOF) neuromuscular twitch
Secondary outcome measures
Time to discharge from the operating room
Time to endotracheal extubation

Trial Design

2Treatment groups
Active Control
Group I: SugammadexActive Control1 Intervention
Muscle relaxant reversal will be attained with sugammadex 2 mg/kgm IV.
Group II: NeostigmineActive Control2 Interventions
Muscle relaxant reversal will be attained with neostigmine 50 mcg/kgm plus glycopyrrolate10 mcg/kgm IV.

Find a Location

Who is running the clinical trial?

University of Kansas Medical CenterLead Sponsor
465 Previous Clinical Trials
169,227 Total Patients Enrolled
5 Trials studying Burns
274 Patients Enrolled for Burns
Anthony Kovac, MDPrincipal InvestigatorUniversity of Kansas Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any significant dangers associated with Sugammadex?

"There is evidence from previous trials to support Sugammadex's efficacy, as well as data from multiple rounds of safety testing. Consequently, our team has rated Sugammadex as a 3 on our safety scale."

Answered by AI

Could elderly patients be enrolled in this research project?

"Based on the age requirements for this trial, the youngest a patient can be is 18 years old and the oldest is 65."

Answered by AI

What are the most common conditions that Sugammadex is used to help alleviate?

"Sugammadex has a broad range of potential uses, including the treatment of intestines, general surgery, prophylaxis of post-operative urinary retention, and chronic bronchitis."

Answered by AI

Are there other instances where Sugammadex has been used in a medical setting?

"There are twenty-eight clinical trials that are currently underway concerning sugammadex. Of these, four are in Phase 3. Though the majority of research concerning sugammadex is based in Morgantown, West virginia, there are one thousand and ninety-three locations running studies concerning sugammadex."

Answered by AI

How many total enrollees are needed for this research project?

"That is correct, the clinicaltrials.gov website has updated information which suggests that this study is looking for 40 patients from a single location. This research was first posted on 3/15/2018 and was last updated on 5/2/2022."

Answered by AI

Would you happen to know if this particular medical study is still enrolling patients?

"The listed clinical trial on clinicaltrials.gov is currently seeking patients. This particular trial was originally posted on March 15th, 2018 and was updated as recently as May 2nd, 2022."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Comparison of Reversal of Neuromuscular Blockade With Sugammadex Versus Neostigmine Plus Glycopyrolate in Patients Undergoing Burn Surgery
2018. "Comparison of Reversal of Neuromuscular Blockade With Sugammadex Versus Neostigmine Plus Glycopyrolate in Patients Undergoing Burn Surgery". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03513406.
~1 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top